Kushenol B exhibits significant anti-inflammatory and immunomodulatory properties, making it a candidate for development in treating autoimmune disorders such as rheumatoid arthritis and lupus. It has shown inhibitory effects on pro-inflammatory cytokines, particularly TNF-α and IL-6, which play key roles in chronic inflammation. Additionally, Kushenol B demonstrates antiviral activity, especially against hepatitis B virus, by interfering with viral replication pathways. Its ability to induce apoptosis in certain cancer cell lines suggests potential as an adjuvant in oncology therapies. Research is ongoing to explore its use in dermatological formulations due to its antioxidant effects and capacity to protect skin cells from oxidative stress.